Related Experiment Videos
Partial irradiation of the rectum.
1Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021, USA.
Seminars in Radiation Oncology
|July 12, 2001
Summary
Careful conformal radiotherapy techniques significantly reduce severe rectal toxicity in prostate cancer patients. Current challenges include managing rectal bleeding, influenced by dose-volume effects and rectal motion during treatment.
Area of Science:
- Radiation Oncology
- Gastrointestinal Oncology
Background:
- Rectal toxicity is a known complication of prostate cancer radiotherapy.
- Conformal techniques have improved outcomes, but gastrointestinal issues persist.
Purpose of the Study:
- To analyze rectal toxicity in prostate cancer patients treated with conformal radiotherapy over the last decade.
- To identify factors influencing rectal complications and optimize treatment planning.
Main Methods:
- Review of dose escalation protocols for prostate cancer.
- Analysis of rectal motion and its impact on dose delivery.
- Evaluation of dose-volume histograms (DVHs) and their correlation with toxicity.
Main Results:
- Severe rectal complications like obstruction and fistula are now rare.
- Rectal bleeding due to telangiectasia is the most common issue.
- Rectal motion necessitates smaller planning target volume (PTV) margins (approx. 0.6 cm) and shielding to reduce toxicity.
- Dose-volume effects, particularly exposure above 70 Gy and between 40-50 Gy, influence rectal toxicity rates.
Conclusions:
- Advanced conformal techniques have minimized severe rectal injury.
- Optimizing PTV margins and utilizing DVH analysis are crucial for managing rectal bleeding and toxicity in prostate cancer radiotherapy.